TG Therapeutics, Inc. (TGTX)
NASDAQ: TGTX · Real-Time Price · USD
31.82
+0.07 (0.22%)
Mar 30, 2026, 11:46 AM EDT - Market open
TG Therapeutics Employees
TG Therapeutics had 399 employees as of December 31, 2025. The number of employees increased by 61 or 18.05% compared to the previous year.
Employees
399
Change
61
Growth
18.05%
Revenue / Employee
$1,544,579
Profits / Employee
$1,120,749
Market Cap
4.70B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 399 | 61 | 18.05% |
| Sep 30, 2025 | 374 | 55 | 17.24% |
| Jun 30, 2025 | 370 | 70 | 23.33% |
| Mar 31, 2025 | 352 | 68 | 23.94% |
| Dec 31, 2024 | 338 | 74 | 28.03% |
| Sep 30, 2024 | 319 | 74 | 30.20% |
| Jun 30, 2024 | 300 | 56 | 22.95% |
| Mar 31, 2024 | 284 | 47 | 19.83% |
| Dec 31, 2023 | 264 | 38 | 16.81% |
| Sep 30, 2023 | 245 | 59 | 31.72% |
| Jun 30, 2023 | 244 | 71 | 41.04% |
| Mar 31, 2023 | 237 | 18 | 8.22% |
| Dec 31, 2022 | 226 | -60 | -20.98% |
| Sep 30, 2022 | 186 | -179 | -49.04% |
| Jun 30, 2022 | 173 | -155 | -47.26% |
| Mar 31, 2022 | 219 | -82 | -27.24% |
| Dec 31, 2021 | 286 | 14 | 5.15% |
| Sep 30, 2021 | 365 | 148 | 68.20% |
| Jun 30, 2021 | 328 | 152 | 86.36% |
| Mar 31, 2021 | 301 | 148 | 96.73% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Caris Life Sciences | 1,846 |
| Amicus Therapeutics | 511 |
| Rhythm Pharmaceuticals | 414 |
| CRISPR Therapeutics AG | 393 |
| Xenon Pharmaceuticals | 370 |
| Immunovant | 362 |
| Scholar Rock Holding | 289 |
| Celcuity | 155 |
TGTX News
- 11 days ago - TG Therapeutics Secures an Additional $500 Million in Non-Dilutive Capital from Blue Owl and Expands Share Repurchase Program to $300 Million - GlobeNewsWire
- 21 days ago - Data Published in Neurology and Therapy Demonstrate Significant Reductions in Relapse and MRI Activity with BRIUMVI® in People with Highly Active Relapsing Multiple Sclerosis - GlobeNewsWire
- 24 days ago - TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI® (ublituximab) in Multiple Sclerosis at the American Academy of Neurology 2026 Annual Meeting - GlobeNewsWire
- 4 weeks ago - Precision BioSciences Receives $7.5M in Proceeds from TG Therapeutics for Azer-cel Clinical Milestone in Multiple Sclerosis - Business Wire
- 4 weeks ago - TG Therapeutics: 'Strong Buy' On BRIUMVI's Massive Growth And Possible Expansion - Seeking Alpha
- 4 weeks ago - TG Therapeutics, Inc. (TGTX) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - TG Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Raises BRIUMVI Revenue Guidance - GlobeNewsWire
- 5 weeks ago - TG Therapeutics to Host Conference Call on Fourth Quarter and Full Year 2025 Financial Results and Business Update - GlobeNewsWire